HSON vs NSRX
Comparison between (HSON, Company) and Nasus Pharma Ltd (NSRX, Company).
HSON vs NSRX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
HSON
$28M
NSRX
$28M
Max Drawdown
Winner
HSON
3.74%
NSRX
78.03%
Sharpe Ratio
HSON
-4.85
Winner
NSRX
-0.58
5Y Beta
HSON
N/A
NSRX
0.91
Industry
HSON
N/A
NSRX
Drug Manufacturers - General
P/E Ratio
Winner
HSON
-7.15
NSRX
-4.73
PEG Ratio
HSON
N/A
NSRX
-0.02
Debt to Equity
HSON
0.00%
NSRX
0.00%
Free Cash Flow Yield
Winner
HSON
9.22%
NSRX
-17.82%
P/S Ratio
HSON
0.20
NSRX
N/A
P/B Ratio
HSON
0.69
NSRX
N/A
HSON vs NSRX - Historical Returns
Returns include dividend reinvestment.
1M
HSON
N/A
NSRX
+11.64%
3M
HSON
N/A
NSRX
+17.18%
6M
HSON
N/A
NSRX
-51.81%
1Y
HSON
N/A
NSRX
-62.79%
Max(CAGR)
HSON
-80.97%
Winner
NSRX
-68.92%
HSON vs NSRX - Annual Returns (2025 - 2026)
Returns include dividend reinvestment.
| Year | HSON | NSRX |
|---|---|---|
| 2026 | N/A | -59.34% |
| 2025 | -1.80% | +10.91% |
HSON vs NSRX Drawdown Comparison
The maximum drawdown for HSON was -3.74%, occurring on Sep 9, 2025. This drawdown has not yet recovered.
The maximum drawdown for NSRX was -78.03%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current HSON drawdown is -3.74%. The current NSRX drawdown is -66.45%.
| Rank | HSON | NSRX |
|---|---|---|
| #1 | -3.74% Sep 8, 2025 - Sep 9, 2025 | -78.03% Dec 31, 2025 - Mar 30, 2026 |
| #2 | N/A | -30.96% Aug 19, 2025 - Dec 31, 2025 |
| #3 | N/A | -2.42% Aug 13, 2025 - Aug 18, 2025 |
Correlation
Correlation between HSON and NSRX is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: HSON vs SPYNSRX vs SPY
More Comparisons
Compare with similar stocks